1. Home
  2. OSPN vs ENTA Comparison

OSPN vs ENTA Comparison

Compare OSPN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$11.15

Market Cap

449.1M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.40

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
ENTA
Founded
1991
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
486.3M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
OSPN
ENTA
Price
$11.15
$13.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$17.00
$20.40
AVG Volume (30 Days)
476.8K
221.4K
Earning Date
02-26-2026
02-09-2026
Dividend Yield
4.29%
N/A
EPS Growth
99.92
N/A
EPS
1.49
N/A
Revenue
$241,436,000.00
$65,324,000.00
Revenue This Year
$0.69
$0.99
Revenue Next Year
$1.96
$0.19
P/E Ratio
$7.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.00
$4.09
52 Week High
$20.37
$17.15

Technical Indicators

Market Signals
Indicator
OSPN
ENTA
Relative Strength Index (RSI) 33.97 50.82
Support Level $11.26 $12.45
Resistance Level $12.21 $13.66
Average True Range (ATR) 0.52 0.56
MACD -0.08 0.09
Stochastic Oscillator 38.16 75.75

Price Performance

Historical Comparison
OSPN
ENTA

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: